External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Cure SMA 2023

-
Coming soon
02:40 PM
Duration 20mins Walt Disney World Swan Hotel
RISDIPLAM▼ EXPERIENCE FOLLOWING ONASEMNOGENE ABEPARVOVEC IN INDIVIDUALS WITH SPINAL MUSCULAR ATROPHY: A MULTICENTER CASE SERIES
Melissa Svoboda, Carmen Leon Astudillo, Barry Byrne, Jena Krueger, Nancy Kuntz, Jennifer Kwon, Cory Seiburg, Diana Castro

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:00 AM
Duration 20mins Walt Disney World Swan Hotel
FIREFISH Parts 1 and 2: 48-month safety and efficacy of risdiplam▼ in Type 1 SMA
G Baranello, M Mazurkiewicz-Bełdzińska, O Boespflug-Tanguy, JW Day, N Deconinck, A Klein, R Masson, E Mercuri, K Rose, L Servais, D Vlodavets, H Xiong, E Zanoteli, M El-Khairi, M Gerber, K Gorni, H Kletzl, L Palfreeman, A Dodman, BT Darras

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:20 AM
Duration 20mins Walt Disney World Swan Hotel
SUNFISH Parts 1 and 2: 4-year efficacy and safety of risdiplam▼ in Types 2 and 3 SMA
JW Day, N Deconinck, ES Mazzone, A Nascimento, M Oskoui, K Saito, C Vuillerot, G Baranello, O Boespflug-Tanguy, N Goemans, J Kirschner, A Kostera-Pruszczyk, L Servais, J Braid, G Papp, K Gorni, C Martin, WY Yeung, E Mercuri

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar